Concord Biotech | 23/08/2023 | By Sudeep Soparkar | 538
Concord Biotech files DRHP for IPO
Concord Biotech is the leading global developer and manufacturer of select fermentation-based APIs across immunosuppressants and oncology
Concord Biotech | 16/08/2022 | By Sudeep Soparkar | 446
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy